Cathepsin-B and cathepsin-L expression levels do not correlate with sensitivity of tumour cells to TNF-α-mediated apoptosis
2003

Cathepsin-B and Cathepsin-L Levels and Tumor Cell Sensitivity to Apoptosis

publication Evidence: moderate

Author Information

Author(s): Gewies A, Grimm S

Primary Institution: Max-Planck-Institute for Biochemistry

Hypothesis

Do high levels of cathepsin expression enhance the sensitivity of tumor cells to TNF-mediated apoptosis?

Conclusion

The study found that overexpression of cathepsin-B and cathepsin-L does not increase the sensitivity of tumor cells to TNF-induced apoptosis.

Supporting Evidence

  • Cathepsin inhibitors reduced TNF-induced cell death in HeLa cells.
  • Overexpression of cathepsin-B and cathepsin-L did not enhance apoptosis sensitivity.
  • Cathepsin activity was significantly increased in transfected cells.

Takeaway

The researchers wanted to see if having more cathepsins in cancer cells would make them die easier when treated with a specific signal, but it turns out it doesn't help.

Methodology

The study involved transfecting HeLa and PC3 cells with cathepsin expression vectors and assessing apoptosis through various assays including FACS analysis and MTT assays.

Limitations

The study did not explore the effects of other potential cathepsin-like proteases that may influence apoptosis.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6601297

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication